ライフサイエンスコーパス: vaginosis

1 obiota, 4-6 intermediate, and 7-10 bacterial vaginosis).

2 is (one of the causative agents of bacterial vaginosis).

3 in women who are asymptomatic for bacterial vaginosis.

4 s before enrollment, 131 (39%) had bacterial vaginosis.

5 ng asymptomatic pregnant women for bacterial vaginosis.

6 -risk pregnancies for asymptomatic bacterial vaginosis.

7 gical constituents responsible for bacterial vaginosis.

8 sociated with an increased risk of bacterial vaginosis.

9 cytokine expression in response to bacterial vaginosis.

10 cing lactobacilli among women with bacterial vaginosis.

11 rder that were highly specific for bacterial vaginosis.

12 sease acquisition among women with bacterial vaginosis.

13 males, incident trichomoniasis and bacterial vaginosis.

14 s a probiotic for the treatment of bacterial vaginosis.

15 initis, Trichomonas vaginitis, and bacterial vaginosis.

16 -9 use on vaginal lactobacilli and bacterial vaginosis.

17 ing studies on the pathogenesis of bacterial vaginosis.

18 ally transmitted infections during bacterial vaginosis.

19 ial agent used in the treatment of bacterial vaginosis.

20 nt scores but not among women with bacterial vaginosis.

21 dnerella vaginalis predominates in bacterial vaginosis.

22 with presumed bacterial agents of Bacterial vaginosis.

23 ompared with women with no STIs or bacterial vaginosis.

24 play a role in the pathogenesis of bacterial vaginosis.

25 d as a factor for the diagnosis of bacterial vaginosis.

26 o vaginal symptoms associated with bacterial vaginosis.

27 40.2% were classified as involving bacterial vaginosis.

28 ian cancer (4 studies; n = 26432), bacterial vaginosis (2 studies; n = 930), trichomoniasis (1 study;

29 lis, 17.8% (12.4%-23.1%; n = 822), bacterial vaginosis, 37.6% (18.0%-57.2%; n = 1208), peripheral mal

30 is, 29.1% (20.9%-37.2%; n = 5502), bacterial vaginosis, 50.8% (43.3%-58.4%; n = 4280), peripheral mal

31 Bacterial vaginosis, a common disorder among young women, is assoc

32 ukin-8 (IL-8) was not increased in bacterial vaginosis, accounting for low concentrations of neutroph

33 Bacterial vaginosis affects millions of women and is associated wi

34 The prevalence of bacterial vaginosis among lesbians is high.

35 es analyzed, 10 from patients with bacterial vaginosis and 10 from patients without bacterial vaginos

36 aginal fluid from 27 subjects with bacterial vaginosis and 46 without the condition.

37 ed, since prevention strategies of bacterial vaginosis and colonization by certain biotypes of G. vag

38 ciated with M. genitalium, whereas bacterial vaginosis and cunnilingus were negatively associated.

39 other black (ACB) women, including bacterial vaginosis and herpes simplex virus type-2 (HSV-2) infect

40 an women with a high prevalence of bacterial vaginosis and high adherence to PrEP, the efficacy of da

41 antimicrobial polypeptides in both bacterial vaginosis and in vulvovaginal candidiasis, suggesting th

42 d no association between confirmed bacterial vaginosis and MHM (OR: 1.07, 95% CI: 0.52-2.24).

43 rizes our current understanding of bacterial vaginosis and where future research should be focused.

44 and 99 nonpregnant women, all with bacterial vaginosis and without concurrent sexually transmitted in

45 educes HPV, genital ulcer disease, bacterial vaginosis, and trichomoniasis among female partners.

46 s, vaginal discharge, candidiasis, bacterial vaginosis, and trichomoniasis.

47 nsmitter (i.e., male circumcision, bacterial vaginosis, and use of acyclovir) explained 46% of variat

48 lly diagnosed vaginal candidiasis, bacterial vaginosis, and vaginal trichomoniasis using some combina

49 er excluding women with concurrent bacterial vaginosis, another possible cause of vaginal symptoms, t

50 Abnormal vaginal flora and bacterial vaginosis are associated with amplified risks of late mi

51 recommended treatment options for bacterial vaginosis are associated with high rates of recurrence.

52 ks and 2) body mass index <19.8 or bacterial vaginosis as assessed by Gram stain.

53 l population who have asymptomatic bacterial vaginosis (as diagnosed on the basis of vaginal Gram's s

54 ent co-occurrence of Mycoplasma and bacteria vaginosis associated bacteria 3 (BVAB3) among black and

55 est evidence to date for a risk of bacterial vaginosis associated with douching.

56 Resistance to clindamycin by bacterial vaginosis-associated anaerobic organisms has also been d

57 The role of newly defined bacterial vaginosis-associated bacteria (BVAB), which have a speci

58 ng regarding the potential role of bacterial vaginosis-associated bacteria in urethritis, although re

59 by colonization with commensal and bacterial vaginosis-associated bacteria.

60 including increased frequencies of bacterial vaginosis-associated bacterium 1 [BVAB1], BVAB2, BVAB3,

61 vaginosis (BV)--Atopobium vaginae, Bacterial Vaginosis-Associated Bacterium 2 (BVAB-2), Gardnerella v

62 the presence and concentration of bacterial vaginosis-associated microbes and commensal Lactobacillu

63 edian age 33 years), 357 (24%) had bacterial vaginosis at enrolment.

64 prevalent bacteria associated with bacterial vaginosis (Atopobium vaginae and Prevotella bivia).

65 andida, gastrointestinal- system, vaginitis, vaginosis-bacterial, and related terms.

66 highly prevalent in subjects with bacterial vaginosis but rare in healthy controls.

67 Bacterial vaginosis (BV) affects almost a quarter of US women, mak

68 a significant association between bacterial vaginosis (BV) and acquisition of sexually transmitted d

69 sed the association between recent bacterial vaginosis (BV) and incident Mycoplasma genitalium, a sex

70 bacterial species associated with bacterial vaginosis (BV) and its significant adverse sequelae, inc

71 surrounds the association between bacterial vaginosis (BV) and pelvic inflammatory disease (PID).

72 ted in vaginal infections, notably bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), parti

73 ce, sexual behavior, and suspected bacterial vaginosis (BV) as defined by Nugent Gram stain score >/=

74 cribed as normal, intermediate, or bacterial vaginosis (BV) as defined by Nugent's criteria.

75 to assess the relationship between bacterial vaginosis (BV) assessed by Gram stain and incident trich

76 thogenesis and transmissibility of bacterial vaginosis (BV) because it can be diagnosed in both membe

77 microbes isolated from women with bacterial vaginosis (BV) before and after therapy, 119 nonpregnant

78 ave been detected in subjects with bacterial vaginosis (BV) by using broad-range PCR assays, but this

79 women have a higher prevalence of bacterial vaginosis (BV) compared to HSV-2-seronegative women.

80 Women with bacterial vaginosis (BV) display reduced vaginal acidity, which ma

81 Women with bacterial vaginosis (BV) have complex communities of anaerobic bac

82 ly transmitted diseases (STDs) and bacterial vaginosis (BV) have increased rates of cytomegalovirus (

83 Bacterial vaginosis (BV) in pregnancy is linked to preterm birth,

84 Bacterial vaginosis (BV) is a clinical syndrome presenting with a

85 Bacterial vaginosis (BV) is a common clinical syndrome in which th

86 Bacterial vaginosis (BV) is a common disorder characterized by inc

87 Bacterial vaginosis (BV) is a common polymicrobial disease associa

88 Bacterial vaginosis (BV) is a common polymicrobial imbalance of th

89 Bacterial vaginosis (BV) is a perturbation of vaginal flora charac

90 Bacterial vaginosis (BV) is a polymicrobial imbalance of the vagin

91 Bacterial vaginosis (BV) is associated with an increased rate of s

92 Bacterial vaginosis (BV) is associated with complications of pregn

93 Bacterial vaginosis (BV) is associated with human immunodeficiency

94 Bacterial vaginosis (BV) is associated with increased risk of obst

95 Bacterial vaginosis (BV) is characterized by dramatic changes in t

96 Bacterial vaginosis (BV) is characterized by low abundance of Lact

97 ndard" method for the diagnosis of bacterial vaginosis (BV) is lacking.

98 Bacterial vaginosis (BV) is one of the most common causes of vagin

99 Bacterial vaginosis (BV) is the most common cause of vaginal disch

100 Bacterial vaginosis (BV) is the most common gynecological infectio

101 Bacterial vaginosis (BV) is the worldwide leading vaginal disorder

102 Bacterial vaginosis (BV) may be common among women who report havi

103 c vaginal bacteria associated with bacterial vaginosis (BV) may increase the risk of adverse health o

104 Bacterial vaginosis (BV) may increase women's susceptibility to se

105 rus (HPV) infection is affected by bacterial vaginosis (BV) or Trichomonas vaginalis (TV) infection h

106 Bacterial vaginosis (BV) recurrence posttreatment is common.

107 test were compared with a unified bacterial-vaginosis (BV) reference standard incorporating both Nug

108 Bacterial vaginosis (BV) represents shifts in microbiota from Lact

109 bacteria have been associated with bacterial vaginosis (BV) using broad-range bacterial PCR methods s

110 t anaerobe, Atopobium vaginae, and bacterial vaginosis (BV) warrants further investigation.

111 sma hominis, and Candida albicans; bacterial vaginosis (BV) was identified by clinical criteria.

112 Bacterial vaginosis (BV) was identified recently as a cofactor tha

113 -year follow-up, 50 women acquired bacterial vaginosis (BV), 25 acquired symptomatic vulvovaginal can

114 Bacterial vaginosis (BV), a disruption of the normal vaginal flora

115 al colonization with lactobacilli, bacterial vaginosis (BV), and acquisition of human immunodeficienc

116 rformed to determine the burden of bacterial vaginosis (BV), and behavioral factors influencing the v

117 ifetime sexual partners, syphilis, bacterial vaginosis (BV), and vaginal candidiasis.

118 enii vaginally and/or rectally had bacterial vaginosis (BV), compared with 12 (44%) of 27 females col

119 espite the worldwide prevalence of bacterial vaginosis (BV), its etiology is still unknown.

120 itis commonly occurs in women with bacterial vaginosis (BV), often without concomitant chlamydial or

121 requently isolated from women with bacterial vaginosis (BV), produces a cholesterol-dependent cytolys

122 e expert technical consultation on bacterial vaginosis (BV), sponsored by the National Institute of A

123 During bacterial vaginosis (BV), there is a loss of vaginal acidity, and

124 The primary end points were bacterial vaginosis (BV), vaginal candidiasis, trichomoniasis vagi

125 more vaginal infections, including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or Trich

126 experts technical consultation on bacterial vaginosis (BV), where data regarding controversies over

127 ve indicators for the diagnosis of bacterial vaginosis (BV)--Atopobium vaginae, Bacterial Vaginosis-A

128 tic approaches to the treatment of bacterial vaginosis (BV).

129 s the most common species found in bacterial vaginosis (BV).

130 terations induced by pregnancy and bacterial vaginosis (BV).

131 ive (HIV(-)) women with or without bacterial vaginosis (BV).

132 enital inflammation and persistent bacterial vaginosis (BV); this subtype could be predicted with hig

133 r recurrent genital herpes, having bacterial vaginosis by Nugent criteria, and having had two or more

134 %) but a low specificity (zero for bacterial vaginosis, candida, and Trichomonas vaginalis).

135 Samples for detection of bacterial vaginosis, Chlamydia trachomatis, and Neisseria gonorrho

136 is enhanced in pregnant women with bacterial vaginosis, compared with that in nonpregnant women.

137 l differences persist for rates of bacterial vaginosis even when other known risk factors are control

138 nd why some but not all women with bacterial vaginosis experience complications.

139 PCR was used to survey bacterial vaginosis flora before and after metronidazole treatment

140 Bacterial vaginosis frequently persists after treatment.

141 entrations, menstrual cycle phase, bacterial vaginosis, genital bleeding, or plasma virus detection.

142 -up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chlamydia infection were sign

143 Among women with bacterial vaginosis, H(2)O(2)-producing lactobacillus colonization

144 Women without bacterial vaginosis had 1 to 6 vaginal bacterial species (phylotyp

145 Women with bacterial vaginosis had greater bacterial diversity (P<0.001), wit

146 Bacterial vaginosis has been associated with preterm birth.

147 int-of-care diagnostic testing for bacterial vaginosis has emerged.

148 Women with bacterial vaginosis have complex vaginal infections with many newl

149 Women with bacterial vaginosis have different microbiological profiles.

150 .72% [95% CI -66.59 to 91.66]), or bacterial vaginosis (HIV incidence 0.9 per 100 person-years in the

151 ual physical examination findings (bacterial vaginosis, homogeneous discharge: sensitivity range, 69%

152 ne chlamydial infection (HR, 5.2), bacterial vaginosis (HR, 2.1), and the occurrence of genital ulcer

153 een reported to be associated with bacterial vaginosis in observational studies.

154 preterm birth by the treatment of bacterial vaginosis in pregnancy are disappointing.

155 enefits and harms of screening for bacterial vaginosis in pregnancy by identifying new evidence addre

156 F) recommendation on screening for bacterial vaginosis in pregnancy.

157 enefits and harms of screening for bacterial vaginosis in pregnant women at high risk for preterm del

158 Do not screen for bacterial vaginosis in pregnant women at low risk for preterm deli

159 The treatment of asymptomatic bacterial vaginosis in pregnant women does not reduce the occurren

160 clinical trials, the treatment of bacterial vaginosis in pregnant women who previously had a preterm

161 ion, vulvovaginal candidiasis, and bacterial vaginosis) in HIV-1-seropositive versus HIV-1-seronegati

162 diagnose abnormal vaginal flora or bacterial vaginosis, in accordance with Nugent's criteria.

163 ylotypes and those associated with bacterial vaginosis, including Atopobium vaginae, were identified

164 es were detected in the women with bacterial vaginosis, including several species with no close culti

165 Bacterial vaginosis increases the susceptibility to sexually trans

166 Bacterial vaginosis is a common condition associated with increase

167 Bacterial vaginosis is a highly prevalent and poorly understood po

168 Bacterial vaginosis is a risk factor for preterm birth.

169 Persistent bacterial vaginosis is associated with several bacteria in the Clo

170 ginal lavage fluid from women with bacterial vaginosis is deficient in antimicrobial polypeptides and

171 Bacterial vaginosis is far more than a nuisance infection.

172 Bacterial vaginosis is the most common lower genital tract syndrom

173 Bacterial vaginosis is the most common vaginal condition and is va

174 Bacterial vaginosis is the most common vaginal disorder in women,

175 normal immunostimulatory flora in bacterial vaginosis is thus associated with a local deficiency of

176 x only with men, or to women whose bacterial vaginosis is treated with oral antibiotics.

177 The etiology of bacterial vaginosis is unknown, and there are no long-term therapi

178 or on examination is predictive of bacterial vaginosis (LR, 3.2 [95% CI, 2.1-4.7]) while lack of odor

179 We investigated whether bacterial vaginosis modified the efficacy of oral PrEP.

180 For bacterial vaginosis (n=73), neither the shedding of HIV-1 RNA (fro

181 nosis and 10 from patients without bacterial vaginosis, none shared the same DNA fingerprint.

182 Women (N = 40) with incident bacterial vaginosis (Nugent 7-10) had significantly lower concentr

183 , the Osmetech Microbial Analyzer--Bacterial Vaginosis (OMA-BV), which determines a patient's BV stat

184 ' gestation (mean 15.6 weeks)--for bacterial vaginosis or abnormal vaginal flora.

185 ore labor for risk factors such as bacterial vaginosis or during preterm labor have not consistently

186 he need for concurrent testing for bacterial vaginosis or vaginal dysbiosis.

187 e (P=.008), and lower frequency of bacterial vaginosis (P<.001) and gonorrhea (P=.03).

188 e whether prevention or control of bacterial vaginosis, particularly approaches that rely not on anti

189 eta-defensin-2 mRNA, but a typical bacterial vaginosis pathogen, Gardnerella vaginalis, had no effect

190 The cause of bacterial vaginosis remains poorly understood despite numerous stu

191 Bacterial vaginosis represents a unique upheaval of the complex va

192 Bacterial vaginosis resolved in 657 of 845 women who had follow-up

193 aginal sex (P = .04) and increased bacterial vaginosis risk (odds ratio, 4.2; 95% confidence interval

194 e the causal effect of douching on bacterial vaginosis risk while controlling for this confounding ef

195 2 weeks reduced the likelihood of bacterial vaginosis (RR, 0.5; 95% CI, 0.3-1.0).

196 mong subgroups of women defined by bacterial vaginosis status based on yearly microscopy and Nugent s

197 rhoeae, Trichomonas vaginalis, and bacterial vaginosis testing were collected from female adolescents

198 nonantibiotic adjunct to existing bacterial vaginosis therapies in order to decrease the risk of chr

199 l, and to explore the relevance of bacterial vaginosis to other adverse pregnancy outcomes, such as d

200 idelines for gonorrhea, chlamydia, bacterial vaginosis, trichomonas, vulvovaginal candidiasis, pelvic

201 Each diagnostic accuracy study for bacterial vaginosis, trichomoniasis, and genital herpes was perfor

202 ) and lack of perceived odor makes bacterial vaginosis unlikely (LR, 0.07 [95% CI, 0.01-0.51]).

203 sseria gonorrhoeae using NAATs and bacterial vaginosis using Gram stains.

204 ow-up, the incidence of persistent bacterial vaginosis was 26% and was statistically significantly hi

205 Bacterial vaginosis was associated with fewer episodes of VVC (adj

206 Bacterial vaginosis was based on a Nugent's Gram stain score of 7

207 Bacterial vaginosis was treated with intravaginal metronidazole ge

208 rized as normal, intermediate, and bacterial vaginosis were included.

209 is integral to the pathogenesis of bacterial vaginosis, which has substantial implications for the de

210 pective analysis of 947 women with bacterial vaginosis who were enrolled in prospective studies inves

211 tomatic abnormal vaginal flora and bacterial vaginosis with oral clindamycin early in the second trim